What we use radium for

Where does it go, and why this element?

Today radium-223 treats prostate cancer that has spread to the bones, and old radium-226 is a raw material for other medical isotopes. In the past, radium treated cancer and made watch dials glow8.

Last updated 14 October 2026.

Where it goes

The Royal Society of Chemistry says that radium now has few uses, because it is so radioactive1. No source we read gives the shares of these uses, for any year.

One use today is the drug Xofigo (radium-223 dichloride). It treats prostate cancer that no longer responds to hormone treatment and that has spread to the bones, but not to other organs2. The US Food and Drug Administration approved it in 20133.

In 2018 the European Medicines Agency (EMA) restricted its use in the EU. In a trial, patients who got Xofigo with abiraterone and prednisone had more fractures than patients who got a placebo4. The EMA also said that these patients could be at risk of dying earlier4. Now, in the EU, Xofigo is for patients who have had two earlier treatments, or who cannot take other treatments4.

Radium-226 is now used as a raw material. ORNL irradiates it to make actinium-227 for Xofigo (see the production chapter). Other producers use it to make actinium-225, an isotope for new cancer treatments5. The DOE sells research amounts of radium-226 for this work, and not for resale6.

Past uses

For most of the 20th century, the main medical use was cancer treatment with sealed radium-226 sources, called brachytherapy7. Doctors also used radon gas from radium chloride1.

Argonne gives luminous paint for the dials of watches, clocks and instruments as the main use in history8. Radium was also sold in “cures”: radioactive water, salves and tonics9. One such water, Radithor, held at least 1 microcurie each of radium-226 and radium-228 per bottle10.

Why this element

Radium-223 is chemically similar to calcium, so it goes into bone. There its alpha particles kill nearby cancer cells1. Its half-life is about 11.4 days11.

Radium-226 decays slowly. Its half-life is 1,600 years, so a sealed source stays active for many human lifetimes12. In luminous paint, a small amount of radium mixed with zinc sulfide made a paint that glowed in the dark13.

What could replace it

Other isotopes replaced radium-226 in brachytherapy. In a 2026 release, Pacific Northwest National Laboratory (PNNL) names iridium-192 and iodine-125, and external radiation machines14. The IAEA says that the decay products of radium-226 are a serious health risk. It adds that in the last 50 years, more efficient or less hazardous sources have largely replaced it7. Jim Ungrin writes that cobalt-60 helped to end radium refining at Port Hope, Canada11.

We found no source on what replaced radium in luminous paint. We found no source that compares radium-223 with other drugs on price.

Where demand is going

Radium-226 is a raw material for actinium-225. The DOE says that demand for actinium-225 has increased dramatically6. In 2025 the IAEA gave world production of actinium-225 as 1.7 curies a year, enough for about 2,000 patients7. In February 2026 the EORTC, a European cancer research group, gave the final results of the PEACE-3 trial. In this trial, men with prostate cancer that had spread to the bones got Xofigo together with enzalutamide, another prostate cancer drug. The combination reduced the risk of death by 24%, compared with enzalutamide alone15. We found no published forecast of radium demand.

Sources

  1. 1

    Royal Society of Chemistry, 2025. Radium, in the Periodic Table .

    Crustal abundance, production of fewer than 100 grams a year, uses, history and the podcast by Brian Clegg.

    • Radium now has few uses, because it is so highly radioactive.
    • Radium’s main practical use has been in medicine, producing radon gas from radium chloride to be used in radiotherapy for cancer.
    • Because bones contain calcium and radium is in the same group as calcium, it can be used to target cancerous bone cells. It gives off alpha particles that can kill the cancerous cells.
  2. 2

    Oak Ridge National Laboratory, 2018. ORNL ramps up production of key radioisotope for cancer-fighting drug .

    Radium-226 from old medical devices, irradiated to make actinium-227 for Bayer, which extracts radium-223 in Norway. Read with Firecrawl.

    • Xofigo is for men whose prostate cancer has spread to the bone with symptoms but not to other parts of the body.
  3. 3

    Algeta ASA (company release, published by Technology Networks), 2013. Algeta: FDA Approves Xofigo (radium-223 dichloride) .

    The US approval of radium-223 dichloride for prostate cancer with bone metastases.

    • the US Food and Drug Administration (FDA) has approved Xofigo® (radium-223 dichloride) injection
  4. 4

    European Medicines Agency, 2018. EMA restricts use of prostate cancer medicine Xofigo .

    The 2018 review of Xofigo, the fractures and earlier deaths in a trial with abiraterone, and the new limits on use.

    • 29% of patients who received the Xofigo combination had fractures, compared with 11% of patients given the placebo combination
    • could be at risk of dying earlier and had more fractures
    • recommended restricting its use to patients who have had two previous treatments for metastatic prostate cancer (prostate cancer that has spread to the bone) or who cannot receive other treatments
  5. 5

    International Atomic Energy Agency, 2023. Technical Meeting on the Global Radium-226 Management Initiative, Information Sheet .

    Legacy radium-226 stocks as a management problem and as feedstock for actinium-225.

    • The treatment of cancer cells through the application of radiotracers with Actinium-225 shows very promising results and using 226Ra as a feedstock material is an effective production route for the Actinium.
  6. 6

    U.S. Department of Energy, National Isotope Development Center, 2022. Radium-226 is Available Now! .

    Research amounts of radium-226 for sale to make actinium-225, not for resale.

    • research quantities of Ra-226 are available for sale to support this development work
    • This material is not available for resale.
    • demand for actinium-225 (Ac-225) has increased dramatically because new research points to its promise for targeted alpha therapy cancer treatment
  7. 7

    International Atomic Energy Agency, 2025. Recycling old Radium into Cancer Drugs .

    The Global Radium-226 Management Initiative, more than 65 holder countries, the Fiji recovery and world actinium-225 production. Read with Firecrawl.

    • Radium-226 was also used in brachytherapy throughout the 20th century to treat cancer
    • the decay products of this isotope present serious health risks, and, in the last 50 years, it has largely been replaced by other, more efficient or less hazardous radioactive sources
    • Currently, global production of actinium-225 is limited to 1.7 Curies annually, enough to treat approximately 2000 cancer patients.
  8. 8

    Argonne National Laboratory, EVS, 2005. Radium, Human Health Fact Sheet , Radium fact sheet (August 2005), in the collected Argonne fact sheets.

    Abundance, radium in uranium ore, uses, the environment, the body and health effects.

    • Historically, the main use of radium has been as a component in luminous paint used on the dials of watches, clocks, and other instruments, although it is no longer used for this purpose.
    • Historically, the main use of radium has been as a component in luminous paint used on the dials of watches, clocks, and other instruments
  9. 9

    Gary L. Shumway, in San Juan County, Utah - People, Resources, and History (digitized by the J. Willard Marriott Library, University of Utah), 1983. Uranium Mining on the Colorado Plateau , Chapter text, pages 263 to 270.

    Standard Chemical Company, the $120,000 contract price, the National Radium Institute and the Belgian takeover of the market in 1922. Read with Firecrawl.

    • much of it was sold to quacks who used it for medicaments such as radioactive water, salves, tonics, and other nostrums
  10. 10

    Paul Frame, ORAU Museum of Radiation and Radioactivity, 2025. Radithor (ca. 1928) .

    Radithor, its radium content and sales, the death of Eben Byers and the order of the Federal Trade Commission.

    • guaranteed to contain at least 1 microcurie each of Ra-226 and Ra-228
  11. 11

    Jim Ungrin, North Renfrew Times (republished by the Society for the Preservation of Canada's Nuclear Heritage), 2025. Radium and cancer treatments .

    Radium content of uranium ore, prices in the 1920s and 1936, the Port Hope refinery and cobalt-60.

    • radium-223 (half-life 11.4 days)
    • the post-war emergence of a new cancer-treatment material, cobalt-60, eventually led to the cessation of radium refining at Port Hope
  12. 12

    IUPAC Commission on Isotopic Abundances and Atomic Weights (CIAAW), 2024. Radioactive Elements .

    Mass number and half-life of the longest-lived isotope of the 34 elements with no standard atomic weight.

    • 88 Ra radium 226 1600(7) a
  13. 13

    Zachary Dabbs, U.S. National Archives (The Text Message blog), 2018. The Radium Girls at the National Archives .

    The Orange plant, lip pointing, the illnesses, the lawsuits, the 1928 settlement, the LaPorte ruling and the Superfund cleanup.

    • by using a minute quantity of radium in combination with zinc sulfide he could produce a paint with a soft glow visible in the dark
  14. 14

    Pacific Northwest National Laboratory (release published by Newswise), 2026. Legacy Waste Transformed into Strategic Medical Radioisotope Supply .

    The recovery of radium-226 from NIST, the use of radium-226 to make actinium-225, and the replacement of radium in brachytherapy.

    • Radium-226 treatments have been replaced by modern brachytherapy using safer, short-lived isotopes like Iridium-192 and Iodine-125
  15. 15

    European Organisation for Research and Treatment of Cancer (EORTC), 2026. PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases .

    Final results of the PEACE-3 trial of radium-223 with enzalutamide.

    • reducing the risk of death by 24% versus enzalutamide alone